Effect of lectin-like oxidized LDL receptor-1 polymorphism on liver disease, glucose homeostasis, and postprandial lipoprotein metabolism in nonalcoholic steatohepatitis

American Journal of Clinical Nutrition

Volumn 94, Issue 4, 2011, Pages 1033-1042

  Musso, Giovanni ^a   Cassader, Maurizio ^b   De Michieli, Franco ^b   Saba, Francesca ^b   Bo, Simona ^b   Gambino, Roberto ^b  

^a GRADENIGO HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CYTOKERATIN 18; LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; RESISTIN; TRIACYLGLYCEROL;

ADULT; ALLELE; APOPTOSIS; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FAT TOLERANCE TEST; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOPROTEIN METABOLISM; LIVER CELL; LIVER DISEASE; MALE; NONALCOHOLIC FATTY LIVER; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PROTEIN POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOKINES; ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; INSULIN RESISTANCE; INTRONS; ISLETS OF LANGERHANS; ITALY; KERATIN-18; LIPOPROTEINS; LIPOPROTEINS, LDL; LIVER; MALE; PEPTIDE FRAGMENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTPRANDIAL PERIOD; SCAVENGER RECEPTORS, CLASS E; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES;

EID: 80053176429     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.015610     Document Type: Article

References (36)

1. Musso G, Gambino R, Cassader M, Pagano GF. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med (Epub ahead of print 2 November 2010).
2. Holvoet P, De Keyzer D, Jacobs DR. Oxidized LDL and the metabolic syndrome. Future Lipidol 2008;3:637-49.
3. Lu L, Zeng M, Li J, Hua J, Fan J, Fan Z, Dai N, Qiu D, Xiao S. Effects of Kupffer cells stimulated by triglyceride and very low-density lipoprotein on proliferation of rat hepatic stellate cells. Chin Med J (Engl) 1999;112:325-9.
4. Kang Q, Chen A. Curcumin eliminates oxidized LDL roles in activating hepatic stellate cells by suppressing gene expression of lectin-like oxidized LDL receptor-1. Lab Invest 2009;89:1275-90.
5. Ustundag Y, Ozer IO, Yenidunia S. Oxidized low density lipoprotein in liver tissue samples of our NASH patients, alcoholic and chronic viral hepatitis cases. Gastroenterology 2002;57:203.
6. Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 2006;69:36-45. (Pubitemid 41814809)
7. Takanabe-Mori R, Ono K, Sowa N, Wada H, Takaya T, Horie T, Satoh-Asahara N, Shimatsu A, Fujita M, Sawamura T. Lectin-like oxidized low-density lipoprotein receptor-1 is required for the adipose tissue expression of proinflammatory cytokines in high-fat diet-induced obese mice. Biochem Biophys Res Commun 2010;398: 576-80.
8. Rasouli N, Yao-Borengasser A, Varma V, Spencer HJ, McGehee RE Jr, Peterson CA, Mehta JL, Kern PA. Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans. Arterioscler Thromb Vasc Biol 2009;29:1328-35.
9. Mango R, Biocca S, Del Vecchio F, Clementi F, Sangiuolo F, Amati F, Filareto A, Grelli S, Spitalieri P, Filesi I, et al. In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res 2005;97:152-8. (Pubitemid 41033471)
10. Vecchione L, Gargiul E, Borgiani P, Predazzi I, Mango R, Romeo Magnani M, Novelli G. Genotyping OLR1 gene: a genomic biomarker for cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2007; 2:147-51. (Pubitemid 46952446)
11. Musso G, Gambino R, De Michieli F. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003;37:909-16. (Pubitemid 36397404)
12. Musso G, Gambino R, Cassader M. Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis. J Nutr Biochem 2010; 21:834-40.
13. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001;21:3-16. (Pubitemid 32240482)
14. Chang Y, Ryu S, Sung E, Jang Y. Higher concentrations of alanine aminotransferase within the reference interval predict non-alcoholic fatty liver disease. Clin Chem 2007;53:686-92. (Pubitemid 46580239)
15. Pisani P, Faggiano F, Krogh V, Palli D, Vineis P, Berrino F. Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol 1997;26(suppl 1): S152-60. (Pubitemid 27129699)
16. Carnovale E, Marletta L. Food composition table. Istituto Nazionale della Nutrizione. Milano, Italy: EDRA, 1997.
17. Nuñez C, Gallagher D, Visser M, Pi-Sunyer FX, Wang Z, Heymsfield SB. Bioimpedance analysis: evaluation of leg-to-leg system based on pressare contact footpad electrodes. Med Sci Sports Exerc 1997;29: 524-31. (Pubitemid 27183590)
18. Polyzos SA, Toulis KA, Goulis DG, Zavos C, Kountouras J. Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Metabolism 2011;60:313-26.
19. Marra F, Bertolani C. Adipokines in liver diseases. Hepatology 2009; 50:957-69.
20. Pagano C, Soardo G, Pilon C, Milocco C, Basan L, Milan G, Donnini D, Faggian D, Mussap M, Plebani M, et al. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab 2006; 91:1081-6. (Pubitemid 43357784)
21. Musso G, Gambino R, Pacini G, Pagano G, Durazzo M, Cassader M. Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH. Hepatology 2009;49:426-35.
22. Alkhouri N, Carter-Kent C, Feldstein AE. Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications. Expert Rev Gastroenterol Hepatol 2011;5:201-12.
23. Gambino R, Musso G, Cassader MRedox balance in the pathogenesis of nona-alcoholic fatty liver disease: mechanisms and therapeutic opportunities. Antioxid Redox Signal 2011;15:1325-65.
24. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001;24:539-48. (Pubitemid 32198427)
25. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 2007;30:89-94. (Pubitemid 46052504)
26. Cobelli C, Toffolo GM, Dalla Man C, Campioni M, Denti P, Caumo A, Butler P, Rizza R. Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 2007; 293:E1-15.
27. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. What is the best predictor of future type 2 diabetes? Diabetes Care 2007;30: 1544-8. (Pubitemid 46871168)
28. Ishigaki Y, Katagiri H, Gao J, Yamada T, Imai J, Uno K, Hasegawa Y, Kaneko K, Ogihara T, Ishihara H, et al. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Circulation 2008;118: 75-83.
29. Bieghs V, Wouters K, van Gorp PJ, Gijbels MJ, De Winther MP, Binder CJ, Lütjohann D, Febbraio M, Moore KJ, van Bilsen M, et al. Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology 2010;138: 2477-86.
30. Gaemers IC, Stallen JM, Kunne C, Wallner C, van Werven J, Nederveen A, Lamers WH. Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease. Biochim Biophys Acta. 2011;1812: 447-58
31. Njajou OT, Kanaya AM, Holvoet P, Connelly S, Strotmeyer ES, Harris TB, Cummings SR, Hsueh WC. Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study. Diabetes Metab Res Rev 2009; 25:733-9.
32. Kashyap SR, Ioachimescu AG, Gornik HL, Gopan T, Davidson MB, Makdissi A, Major J, Febbraio M, Silverstein RL. Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL. Obesity (Silver Spring) 2009;17:2142-8.
33. Abderrahmani A, Niederhauser G, Favre D, Abdelli S, Ferdaoussi M, Yang JY, Regazzi R, Widmann C, Waeber G. Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells. Diabetologia 2007;50:1304-14. (Pubitemid 46701553)
34. Rütti S, Ehses JA, Sibler RA, Prazak R, Rohrer L, Georgopoulos S, Meier DT, Niclauss N, Berney T, Donath MY, et al. Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. Endocrinology 2009; 150:4521-30.
35. Shin HK, Kim YK, Kim KY, Lee JH, Hong KW. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol. Circulation 2004;109:1022-8. (Pubitemid 38282856)
36. Aramaki Y, Mitsuoka H, Toyohara M, Jinnai T, Kanatani K, Nakajima K, Mukai E, Yamada Y, Kita T, Inagaki N, et al. Lectin-like oxidized LDL receptor-1 (LOX-1) acts as a receptor for remnant-like lipoprotein particles (RLPs) and mediates RLP-induced migration of vascular smooth muscle cells. Atherosclerosis 2008;198:272-9.